✨
AI Summary
- Johnson & Johnson CEO Joaquin Duato discussed focusing on oncology and dementia, not the obesity market.
- Duato highlighted artificial intelligence's potential to speed up drug discovery and development.
- The interview focused on J&J's strategic priorities and future healthcare challenges.
